Emcure Pharmaceuticals Limited — Others, 08-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Emcure Pharmaceuticals Limited has confirmed the securities dematerialization process for the quarter ended March 31, 2025, in compliance with SEBI regulations. The Registrar and Share Transfer Agent, MUFG Intime India Private Limited, reported successfully accepting and processing the securities, ensuring they are listed appropriately on the stock exchanges. This operational update highlights Emcure's commitment to maintaining accurate and timely record-keeping for its shareholders. For investors, this reassurance of compliance and operational integrity suggests a stable governance structure, potentially fostering a positive outlook in the market.